18008891064
info@ikrispharmanetwork.com
Register Now: IKRIS Breast Cancer Awareness Run 2022
About
Who We Are
How can we help
Resellers
RLD/Innovator Sourcing
Patients and Healthcare Professionals
Products
Commercial Products
Own Label
Immunokris
Polymyxin B
Partner Product
BioMarin Products
RECORDATI products
PTC Products
Sarepta
Media Room
Updates
Contact Us
About
×
Search for:
Featured Products
HIV
Abacavir-Lamivudine
Allergic States
,
Dermatologic
,
Endocrine conditions
,
Gastrointestinal Diseases
,
Neoplastic conditions
Prednisolone
Multiple myeloma
Thalidomide
Type-2 diabetes mellitus
Dulaglutide
HIV
Furmecil
Gram-negative bacteria
Amikacin
Trending Articles
Breast cancer
FDA Issues Safety Alert Regarding Reports of SCC in Scar Tissue Around Surrounding Implants
September 15, 2022
2
mins read
Multiple Myeloma
Cipla Gets the Final Approval for Generic Version of Revlimid by US FDA
September 12, 2022
< 1
min read
Acid Sphingomyelinase Deficiency
FDA Approves Xenpozyme: The First Disease-specific Medication for Acid Sphingomyelinase Deficiency (ASMD)
September 8, 2022
2
mins read
Ebola virus
WHO Recommends Two New Lifesaving Medicines to Treat Ebola Virus Disease
August 31, 2022
2
mins read
